Skip to Content
MIT News magazine

New Leadership

John Reed elected chair of MIT Corporation
August 25, 2010

John S. Reed ‘61, SM ‘65, retired chairman and CEO of Citigroup and former chairman of the New York Stock Exchange, has succeeded Dana Mead, PhD ‘67, as chair of the MIT Corporation, the Institute’s governing body.

Mead announced last fall that he would step down as Corporation chair at the end of June. Reed was elected at the June 4 Corporation meeting.

Born in Chicago in 1939, Reed was raised in Argentina and Brazil, where his father was an executive with Armour. He received joint SB and BA degrees from MIT and Washington & Jefferson College before serving for two years as an officer in the U.S. Army Corps of Engineers. Reed earned his master’s degree in management from Sloan in 1965 and joined Citibank shortly thereafter.

Over the next 35 years, Reed ushered in many banking innovations in the United States and raised Citibank’s profile in emerging Asian and Latin American markets. He became the bank’s chairman and CEO in 1984 and led the organization until his retirement in 2000.

Reed became a life member of the MIT Corporation in 1985.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.